PHUONGTHI NGUYEN
Prescription History 1417536392
Pharmacist in Orlando, FL

Active since April 07, 2021
7673 SAINT STEPHENS CT, ORLANDO, FL 32835(407) 399-3679 Get Directions

NPPES record last updated: April 7, 2021. Verified against the NPPES registry weekly; last sync: August 02, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for PHUONGTHI NGUYEN, an active Pharmacist specialist practicing in Orlando, FL. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 142 documented patient claims. Among these therapy options, the most frequently utilized medication is Paxlovid (Eua), which accounts for 54 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

4
Medications
142
Total Claims
142
30-Day Fills
Paxlovid (Eua)
Most Prescribed · 54 claims
View details
4 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by PHUONGTHI NGUYEN in 2023, with prescription volumes, average cost per fill, and FL state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other FL PrescribersVs. FL Avg

About Paxlovid (Eua): The combination of nirmatrelvir tablets and ritonavir tablets is a product that the FDA is allowing to be given for emergency use to treat COVID-19. Show more ▾

The product is also approved to be used in Canada to treat COVID-19. It is used by people who have recently tested positive for coronavirus, have had mild to moderate symptoms for no more than 5 days and are not hospitalized. To receive this product you must also be at high risk for COVID-19 complications due to older age, obesity, or ongoing medical conditions (such as lung or heart disease or diabetes, among others). Talk to your doctor about the risks and benefits of treatment with nirmatrelvir and ritonavir. Nirmatrelvir is a SARS-CoV-2 main protease inhibitor. It works by preventing the growth of the virus that causes COVID-19. Ritonavir increases (boosts) the levels of nirmatrelvir. This helps nirmatrelvir work better. More information about nirmatrelvir and ritonavir is available from the FDA Fact Sheet for Patients, Parents, and Caregivers for Emergency Use and from the Health Canada Patient Medication Information sheet. There is limited information about how safe and effective the combination of nirmatrelvir and ritonavir is for treating COVID-19. Study results show that nirmatrelvir and ritonavir may help people who have recently tested positive for coronavirus stay out of the hospital. This product is not for use by people who are hospitalized due to COVID-19. The information in this document reflects emerging data, which is evolving and subject to reassessment. Users should be aware of these considerations in their review of nirmatrelvir and ritonavir, and it is always the responsibility of treating practitioners to exercise independent judgement in making care decisions.

In 2023, this provider wrote 54 Medicare prescriptions for Paxlovid (Eua), about 2.2 times the volume of the typical Florida prescriber of this medication (25). Medicare paid an average of $6.58 per fill, versus $10.57 statewide.

How often this provider prescribes it

This provider
54
FL average
25.0

This provider prescribes this medication more often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$6.58
FL average
$10.57

This provider's average cost per fill is below the FL average for this medication.

54
30-Day Fills
standardized to 30-day supplies
270
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 50 Medicare prescriptions for Arexvy. Medicare paid an average of $318.99 per fill. No state comparison is available for this medication.

How often this provider prescribes it

No state benchmark is available for this medication.

What Medicare paid per fill

$318.99
Cost per fill

Gross Part D cost per fill; not the patient's out-of-pocket price.

50
30-Day Fills
standardized to 30-day supplies
50
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 25 Medicare prescriptions for Shingrix, about a quarter of the volume of the typical Florida prescriber of this medication (109). Medicare paid an average of $215.00 per fill, versus $196.65 statewide.

How often this provider prescribes it

This provider
25
FL average
109.0

This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$215.00
FL average
$196.65

Gross Part D cost per fill; not the patient's out-of-pocket price.

25
30-Day Fills
standardized to 30-day supplies
25
Days of Medication
total across all patients in 2023

In 2023, this provider wrote 13 Medicare prescriptions for Boostrix Tdap, about a quarter of the volume of the typical Florida prescriber of this medication (54). Medicare paid an average of $67.35 per fill, versus $63.87 statewide.

How often this provider prescribes it

This provider
13
FL average
54.0

This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$67.35
FL average
$63.87

Gross Part D cost per fill; not the patient's out-of-pocket price.

13
30-Day Fills
standardized to 30-day supplies
13
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average FL prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the FL average cost per fill.

About this data. The prescription history for PHUONGTHI NGUYEN is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pharmacist prescribing approach at this Orlando, FL practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among FL prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.